Recent infections among newly diagnosed cases of HIV infection in Spain, 2015–2016. National estimates using cohort data

References

• Unidad de Vigilancia del VIH y Conductas de Riesgo. Vigilancia epidemiológica del VIH y sida en España. Sistema de información sobre nuevos diagnósticos de VIH y registro nacional de casos de sida. Madrid, Spain: Centro Nacional de Epidemiología-Instituto de Salud Carlos III/Plan Nacional sobre el sida-S.G. de Promoción de la Salud y Vigilancia en Salud Pública; 2019.
   Google Scholar
• European Centre for Disease Prevention and Control. HIV/AIDS surveillance in Europe 2020-2019 data. Stockholm (Sweden): ECDC; 2020.
   Google Scholar
• Kassanjee R, Pilcher CD, Keating SM, et al. Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository. AIDS. 2014;28(16):2439–2449.
   PubMed Web of Science ®Google Scholar
• Murphy G, Parry JV. Assays for the detection of recent infections with human immunodeficiency virus type 1. Euro Surveill. 2008;13(36):537–545.
   Google Scholar
• Aghaizu A, Murphy G, Tosswill J, et al. Recent infection testing algorithm (RITA) applied to new HIV diagnoses in England, Wales and Northern Ireland, 2009 to 2011. Euro Surveill. 2014;19(2):20673.
   PubMedGoogle Scholar
• Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA. 2008;300(5):520–529.
   PubMed Web of Science ®Google Scholar
• Le Vu S, Le Strat Y, Barin F, et al. Population-based HIV-1 incidence in France, 2003–08: a modelling analysis. Lancet Infect Dis. 2010;10(10):682–687.
   PubMed Web of Science ®Google Scholar
• Lee LM, McKenna MT. Monitoring the incidence of HIV infection in the United States. Public Health Rep. 2007;122(1):72–79.
   PubMedGoogle Scholar
• Sane J, Heijman T, Hogema B, et al. Identifying recently acquired HIV infections among newly diagnosed men who have sex with men attending STI clinics in The Netherlands. Sex Transm Infect. 2014;90(5):414–417.
   PubMed Web of Science ®Google Scholar
• Romero A, Gonzalez V, Esteve A, et al. Identification of recent HIV-1 infection among newly diagnosed cases in Catalonia, Spain (2006–08). Eur J Public Health. 2012;22(6):802–808.
   PubMed Web of Science ®Google Scholar
• Suligoi B, Regine V, Pugliese L. Recent HIV infections among newly diagnosed HIV cases in Italy. Clin Chim Acta. 2019;493:S561.
   Web of Science ®Google Scholar
• Hofmann A, Hauser A, Zimmermann R, et al. Surveillance of recent HIV infections among newly diagnosed HIV cases in Germany between 2008 and 2014. BMC Infect Dis. 2017;17(1):484.
   PubMedGoogle Scholar
• Semaille C, Cazein F, Pillonel J, et al. Four years of surveillance of recent HIV infections at country level, France, mid 2003–2006: experience and perspectives. Euro Surveill. 2008;13(36):18968.
   PubMedGoogle Scholar
• Dukers NH, Fennema HS, van der Snoek EM, et al. HIV incidence and HIV testing behavior in men who have sex with men: using three incidence sources, The Netherlands, 1984–2005. AIDS. 2007;21(4):491–499.
   PubMed Web of Science ®Google Scholar
• Nozza S, Cozzi-Lepri A, Bai F, et al. Proportion and factors associated with recent HIV infection in a cohort of patients seen for care in Italy over 1996–2014: data from the ICONA Foundation Study cohort. PLoS One. 2017;12(12):e0189045.
   PubMed Web of Science ®Google Scholar
• Monge S, Diez M, Alvarez M, et al. Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007–2012). Clin Microbiol Infect. 2015;21(1):105.e1–105.e5.
   Google Scholar
• Vourli G, Pharris A, Cazein F, et al. Are European HIV cohort data within EuroCoord representative of the diagnosed HIV population? AIDS. 2019;33(1):133–143.
   PubMed Web of Science ®Google Scholar
• Sobrino-Vegas P, Gutierrez F, Berenguer J, et al. [The Cohort of the Spanish HIV Research Network (CoRIS) and its associated biobank; organizational issues, main findings and losses to follow-up]. Enferm Infecc Microbiol Clin. 2011;29(9):645–653.
   PubMed Web of Science ®Google Scholar
• Garcia-Merino I, de Las Cuevas N, Jimenez JL, et al. The Spanish HIV BioBank: a model of cooperative HIV research. Retrovirology. 2009;6:27.
   PubMed Web of Science ®Google Scholar
• Romero A, Gonzalez V, Granell M, et al. Recently acquired HIV infection in Spain (2003–2005): introduction of the serological testing algorithm for recent HIV seroconversion. Sex Transmitt Infect. 2008;85(2):106–110.
   PubMed Web of Science ®Google Scholar
• Widgren K, Skar H, Berglund T, et al. Delayed HIV diagnosis common in Sweden, 2003–2010. Scand J Infect Dis. 2014;46(12):862–867.
   PubMed Web of Science ®Google Scholar
• Rosińska M, Marzec-Bogustawska A, Janiec J, et al. High percentage of recent HIV infection among HIV-positive individuals newly diagnosed at voluntary counseling and testing sites in Poland. AIDS Res Hum Retroviruses. 2013;29(5):805–813.
   PubMed Web of Science ®Google Scholar
• Kassanjee R, Pilcher CD, Busch MP, et al. Viral load criteria and threshold optimization to improve HIV incidence assay characteristics. AIDS. 2016;30(15):2361–2371.
   PubMed Web of Science ®Google Scholar
• Le Vu S, Meyer L, Cazein F, et al. Performance of an immunoassay at detecting recent infection among reported HIV diagnoses. AIDS. 2009;23(13):1773–1779.
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. HIV/AIDS surveillance in Europe 2019–2018 data. Stockholm (Sweden): ECDC; 2019.
   Google Scholar
• Ministerio Sanidad Servicios Sociales e Lgualdad. Guía de recomendaciones para el diagnostico precoz del VIH en el ambito sanitario. Madrid (Spain): MSSI; 2014.
   Google Scholar
• DiNenno EA, Prejean J, Irwin K, et al. Recommendations for HIV screening of gay, bisexual, and other men who have sex with men - United States, 2017. MMWR Morb Mortal Wkly Rep. 2017;66(31):830–832.
   PubMed Web of Science ®Google Scholar
• Mabileau G. From modelling of cost-effectiveness to changes in national HIV testing policies: opttest. Opttest Final Conference Brussels; 2017. Available from: https://www.opttest.eu/Portals/0/Final%20Conference/14A_JdelAmo_Modelling%20data%20cost-effectiveness%20of%20testing%20strategies_OptTEST.pdf?ver=2017-10-27-100250-673
   Google Scholar
• Balayan T, Oprea C, Yurin O, et al. People who inject drugs remain hard-to-reach population across all HIV continuum stages in Central, Eastern and South Eastern Europe - data from Euro-guidelines in Central and Eastern Europe Network. Infect Dis (Lond). 2019;51(4):277–286.
   PubMed Web of Science ®Google Scholar
• Meulbroek M, Ditzel E, Saz J, et al. BCN Checkpoint, a community-based centre for men who have sex with men in Barcelona, Catalonia, Spain, shows high efficiency in HIV detection and linkage to care. HIV Med. 2013;14(3):25–28.
   PubMedGoogle Scholar
• Semaille C, Barin F, Cazein F, et al. Monitoring the dynamics of the HIV epidemic using assays for recent infection and serotyping among new HIV diagnoses: experience after 2 years in France. J Infect Dis. 2007;196(3):377–383.
   PubMed Web of Science ®Google Scholar
• Sobrino-Vegas P, Rodriguez-Urrego J, Berenguer J, et al. Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care. Antivir Ther. 2012;17(1):1–8.
   PubMed Web of Science ®Google Scholar
• Legarth R, Omland LH, Kronborg G, et al. Educational attainment and risk of HIV infection, response to antiretroviral treatment, and mortality in HIV-infected patients. AIDS. 2014;28(3):387–396.
   PubMed Web of Science ®Google Scholar
• Monge S, Del Romero J, Rodriguez C, et al. Socio-demographic factors associated with the progression of HIV infection and the impact of HAART in a seroconverter cohort in Madrid (1986–2009)]. Enferm Infecc Microbiol Clin. 2012;30(3):117–123.
   PubMed Web of Science ®Google Scholar
• Oliva J, Galindo S, Vives N, et al. Delayed diagnosis of HIV infection in Spain. Enferm Infecc Microbiol Clin. 2010;28(9):583–589.
   PubMed Web of Science ®Google Scholar
• Sobrino-Vegas P, Garcia-San Miguel L, Caro-Murillo AM, et al. Delayed diagnosis of HIV infection in a multicenter cohort: prevalence, risk factors, response to HAART and impact on mortality. Curr HIV Res. 2009;7(2):224–230.
   PubMed Web of Science ®Google Scholar
• Mocroft A, Lundgren J, Antinori A, et al. Late presentation for HIV care across Europe: update from the collaboration of observational HIV epidemiological research Europe (COHERE) study, 2010 to 2013. Euro Surveill. 2015;20(47). DOI:10.2807/1560-7917.ES.2015.20.47.30070
   PubMedGoogle Scholar
• Cousins MM, Konikoff J, Sabin D, et al. A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation. PLoS One. 2014;9(6):e101043.
   PubMed Web of Science ®Google Scholar
• Hauser A, Santos-Hoevener C, Meixenberger K, et al. Improved testing of recent HIV-1 infections with the BioRad avidity assay compared to the limiting antigen avidity assay and BED Capture enzyme immunoassay: evaluation using reference sample panels from the German Seroconverter Cohort. PLoS One. 2014;9(6):e98038.
   PubMed Web of Science ®Google Scholar
• Schlusser KE, Konikoff J, Kirkpatrick AR, et al. Short communication: comparison of maxim and sedia limiting antigen assay performance for measuring HIV incidence. AIDS Res Hum Retroviruses. 2017;33(6):555–557.
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Monitoring recently acquired HIV infections in the European context. Stockholm (Sweden): ECDC; 2013.
   Google Scholar